UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

ERJ open research, 2018-04, Vol.4 (2), p.120-2017

2018

Volltextzugriff (PDF)

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

BMC cancer, 2021-06, Vol.21 (1), p.1-711, Article 711

2021

Volltextzugriff (PDF)

Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

Cancers, 2022-08, Vol.14 (16), p.3878

2022

Volltextzugriff (PDF)

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Targeted oncology, 2022-11, Vol.17 (6), p.675-682

2022

Volltextzugriff (PDF)

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Cancers, 2021-03, Vol.13 (5), p.1040

2021

Volltextzugriff (PDF)

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

BMC cancer, 2021-12, Vol.21 (1)

2021

Volltextzugriff (PDF)

Efficacy of extracranial stereotactic body radiation therapy

BMC cancer, 2021-02, Vol.21 (1)

2021

Volltextzugriff (PDF)

Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study

BMC cardiovascular disorders, 2019-09, Vol.19 (1), p.212-212, Article 212

2019

Volltextzugriff (PDF)

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4304-4304

2020

Volltextzugriff (PDF)

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Frontiers in endocrinology (Lausanne), 2013, Vol.3, p.184

2013

Volltextzugriff (PDF)

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Oncotarget, 2017-08, Vol.8 (31), p.50792-50803

2017

Volltextzugriff (PDF)

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20633-e20633

2016

Volltextzugriff (PDF)

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Biotechnology research international, 2016, Vol.2016, p.1-7

2016

Volltextzugriff (PDF)

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Clinical medicine insights. Therapeutics, 2010-01, Vol.2, p.179

2010

Volltextzugriff (PDF)

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20543-e20543

2017

Volltextzugriff (PDF)

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2231-2231

2014

Volltextzugriff (PDF)

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

ESMO open, 2024-06, Vol.9 (6), p.103594, Article 103594

2024

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Volltextzugriff (PDF)

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7511-7511

2014

Volltextzugriff (PDF)

Serum p53 antibodies as early markers of lung cancer

Nature medicine, 1995-07, Vol.1 (7), p.701-702

1995

Volltextzugriff (PDF)

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS7111-TPS7111

2012

Volltextzugriff (PDF)

Adenocarcinoma of the lung in Down syndrome: first clinical report

Tumori, 2013-07, Vol.99 (4), p.e169-e171

2013

Volltextzugriff (PDF)

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

The Lancet regional health. Europe, 2022-11, Vol.22, p.100492-100492, Article 100492

2022

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionMEDLINE

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

Efficacy of extracranial stereotactic body radiation therapy

Peripheral arterial disease and systematic detection of circulating tumor cells: rationale and design of the DETECTOR prospective cohort study

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Serum p53 antibodies as early markers of lung cancer

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Adenocarcinoma of the lung in Down syndrome: first clinical report

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Aktive Filter

Suchergebnisse filtern